News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Albany Molecular Research, Inc. (AMRI) (AMRI) Announces Fourth Quarter 2012 Adjusted EPS of $0.17


2/12/2013 8:01:48 AM

ALBANY, N.Y., Feb. 12, 2013 -- /PRNewswire/ -- AMRI (Nasdaq: AMRI) today reported financial and operating results for the fourth quarter and full year ended December 31, 2012.

Fourth Quarter:

•Adjusted earnings per share of $0.17, an increase of $0.36 from the prior-year period
•Contract revenue of $59.1 million, up 50% from the prior-year period with sequential revenue improvement in Discovery and Large Scale Manufacturing services

Read at Sacramento Bee


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES